Blood Protein Disorders D001796

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Protein Disorders

Description

Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS.   MeSH

Hierarchy View

Subtype Terms (8)

Agammaglobulinemia
24 drugs (22 approved, 2 experimental)

Antithrombin III Deficiency
2 drugs (1 approved, 1 experimental)

Dysgammaglobulinemia
 

Hypergammaglobulinemia
 

Hypoproteinemia
2 approved drugs

Paraproteinemias
21 drugs (17 approved, 4 experimental)


Phase 3 Indicated Drugs (1)


Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.